Please login to the form below

Not currently logged in
Email:
Password:

US and Canada

This page shows the latest US and Canada news and features for those working in and with pharma, biotech and healthcare.

‘Missing protein’ biotech Stoke raises $142m in IPO

Continues pioneering research. Stoke Therapeutics has listed on the Nasdaq in the US, raising $142m to advance its pipeline of drugs that aim to restore missing protein expression in genetic diseases. ... treat the disorder, which affects roughly 35, 000

Latest news

  • Roche/GE’s digital medicine alliance bears first fruit Roche/GE’s digital medicine alliance bears first fruit

    Roche. For now, the dashboard is only available in the US and Canada. ... Thrive has just raised $110m in a Series A financing that will help it develop CancerSEEK, a liquid biopsy test developed at Johns Hopkins University in the US and currently being

  • Sobi shows strong growth despite haemophilia competition Sobi shows strong growth despite haemophilia competition

    countries. Marketing rights to the drugs in the US, Canada and Japan are held by Bioverativ, which was acquired last year by Sanofi. ... The ultra-rare disease therapy was licensed from Novimmune for $452m last year, and gives Sobi an expanded presence

  • The Final Frontier The Final Frontier

    But let’s talk about gabapentin. In Canada and the US, gabapentin is indicated as an adjunctive therapy for patients with epilepsy, who are not adequately controlled with conventional therapy. ... But what I do know is that the legalisation of medical

  • Symkevi approval in Europe helps Vertex expand CF treatment Symkevi approval in Europe helps Vertex expand CF treatment

    The new combination has shown greater efficacy than Orkambi and with fewer side effects. ... The new combination was approved by the FDA and is known as Symdeko in the US and Canada.

  • AZ rival to GSK’s COPD drug Anoro fails head-to-head test AZ rival to GSK’s COPD drug Anoro fails head-to-head test

    At stake is a share of a big and expanding market for COPD therapies, estimated at well over $15bn in the US and top five EU markets alone in 2016 but ... Bevespi is a newer entrant, picking up its first OK in the US in 2016 and also approved in Canada,

More from news
Approximately 0 fully matching, plus 244 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    US. US and Canada only. # US and EU. Roche’s collaboration with Ionis Pharmaceuticals has a headline of $760m, $1m more than the Tusk deal. ... milestones and royalties, and US profits or losses will be split 50:50.

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    She is Alnylam’s senior vice president, Europe and Canada and is based at the firm’s European headquarters in Zug, Switzerland. ... In the US and Canada, the company has launched Alynlam Act, a free of charge genetic testing and counselling service.

  • Deal Watch February 2017 Deal Watch February 2017

    In addition to the upfront and milestone payments, Immunomedics will receive tiered double digit royalties on global net sales, retains an option to co-promote IMMU-132 in the US and ... First approved in North America in 1989, Zoladex sales in 2016 were

  • 2016: The year when deal-makers took stock? 2016: The year when deal-makers took stock?

    Compounding this was the current political uncertainty following regime change in the US and Brexit, with the latter appearing to encourage caution in deal-making which may well continue into 2017. ... This has provided an opportunity for companies

  • Deal Watch October 2016 Deal Watch October 2016

    $4, 300 royalty. Buyout of collaboration. Respiratory 2015. Actavis US and Canada. ... The biosimilar market is heating up. This month Teva has entered into a US and Canada commercialisation arrangement with South Korea's Celltrion.

More from intelligence
Approximately 0 fully matching, plus 35 partially matching documents found.

Latest appointments

  • NDA bolsters its senior team NDA bolsters its senior team

    US, Europe, Canada and other markets. ... Her contributions will help propel client strategy and accelerate programmes across the EU and US, as well as result in new intriguing service offerings that enable innovative companies to navigate the

  • Celgene’s president and COO to retire Celgene’s president and COO to retire

    Smith has over 30 years of business strategy experience across a range of therapeutic areas, having previously held senior leadership roles at Biovail in Canada, France, the US and Hong Kong, ... Smith's successor, Curran, joined Celgene in 2013 as the

  • Bayer appoints president of Americas pharma business Bayer appoints president of Americas pharma business

    Dr Carsten Brunn to lead operations across the US, Canada, Central and Latin America. ... Bayer has appointed Dr Carsten Brunn as the president of its pharmaceuticals business in the Americas, overseeing the company's operations in the US, Canada and

  • Vikas Sinha joins Verona as non-executive director Vikas Sinha joins Verona as non-executive director

    Brings strong US and financial experience to the UK drug development firm. ... Prior to that he spent 11 years at Bayer, holding roles in the US, Canada, Japan and Germany, latterly as chief financial officer for Bayer Pharmaceuticals Corporation in the

  • Merck appoints new North America and China biopharma leaders Merck appoints new North America and China biopharma leaders

    He will be responsible for the Massachusetts-based biopharma business' strategic direction and growth across the US and Canada. . ... chief commercial officer for the US.

More from appointments
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
JPA Health Communications

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Webinar: Usability and UX: You’ve been asked to test...What next?
Thursday 27th June 2019 10am EDT / 3pm BST / 4pm CEST...
Event: EphMRA Annual Conference
We're sponsoring, exhibiting and presenting three papers at this year’s EphMRA Annual Conference in Warsaw, Poland....
Research Partnership and Janssen awarded runner-up in MR Excellence Awards
...

Infographics